As in GCB-DLBCL, the tumor suppressor, p53, and cell cycle checkpoint proteins, p21 and p27, are deregulated by activated BCL6, resulting in centrosome abnormality and cell-cycle progression (32, 33). This evidence concerns the gene BCL6 and diffuse large B-cell lymphoma.